GO:0005643 | nuclear pore | 8.67e-05 | 8.46e-01 | 5.078 | 3 | 12 | 51 |
GO:0008380 | RNA splicing | 1.58e-04 | 1.00e+00 | 3.800 | 4 | 21 | 165 |
GO:0005654 | nucleoplasm | 3.97e-04 | 1.00e+00 | 2.199 | 7 | 68 | 876 |
GO:0008180 | COP9 signalosome | 7.70e-04 | 1.00e+00 | 5.581 | 2 | 6 | 24 |
GO:0000398 | mRNA splicing, via spliceosome | 1.31e-03 | 1.00e+00 | 3.751 | 3 | 15 | 128 |
GO:0004832 | valine-tRNA ligase activity | 1.74e-03 | 1.00e+00 | 9.166 | 1 | 1 | 1 |
GO:0032859 | activation of Ral GTPase activity | 1.74e-03 | 1.00e+00 | 9.166 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 1.74e-03 | 1.00e+00 | 9.166 | 1 | 1 | 1 |
GO:0005098 | Ran GTPase activator activity | 1.74e-03 | 1.00e+00 | 9.166 | 1 | 1 | 1 |
GO:0005634 | nucleus | 1.81e-03 | 1.00e+00 | 1.086 | 12 | 158 | 3246 |
GO:0051028 | mRNA transport | 2.95e-03 | 1.00e+00 | 4.611 | 2 | 5 | 47 |
GO:0003677 | DNA binding | 3.97e-03 | 1.00e+00 | 1.864 | 6 | 52 | 947 |
GO:0000777 | condensed chromosome kinetochore | 4.30e-03 | 1.00e+00 | 4.333 | 2 | 6 | 57 |
GO:0042826 | histone deacetylase binding | 4.45e-03 | 1.00e+00 | 4.308 | 2 | 5 | 58 |
GO:0000785 | chromatin | 4.60e-03 | 1.00e+00 | 4.283 | 2 | 6 | 59 |
GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 5.21e-03 | 1.00e+00 | 7.581 | 1 | 1 | 3 |
GO:0046914 | transition metal ion binding | 5.21e-03 | 1.00e+00 | 7.581 | 1 | 1 | 3 |
GO:0065002 | intracellular protein transmembrane transport | 5.21e-03 | 1.00e+00 | 7.581 | 1 | 1 | 3 |
GO:0032853 | positive regulation of Ran GTPase activity | 5.21e-03 | 1.00e+00 | 7.581 | 1 | 1 | 3 |
GO:2001275 | positive regulation of glucose import in response to insulin stimulus | 5.21e-03 | 1.00e+00 | 7.581 | 1 | 1 | 3 |
GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 1 | 4 |
GO:0007000 | nucleolus organization | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 1 | 4 |
GO:0071156 | regulation of cell cycle arrest | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 2 | 4 |
GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 6.95e-03 | 1.00e+00 | 7.166 | 1 | 1 | 4 |
GO:0016363 | nuclear matrix | 6.97e-03 | 1.00e+00 | 3.976 | 2 | 10 | 73 |
GO:0001649 | osteoblast differentiation | 7.16e-03 | 1.00e+00 | 3.956 | 2 | 5 | 74 |
GO:0032287 | peripheral nervous system myelin maintenance | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 2 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 1 | 5 |
GO:0031340 | positive regulation of vesicle fusion | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 1 | 5 |
GO:0042382 | paraspeckles | 8.68e-03 | 1.00e+00 | 6.844 | 1 | 3 | 5 |
GO:0044822 | poly(A) RNA binding | 9.76e-03 | 1.00e+00 | 1.846 | 5 | 45 | 799 |
GO:0050847 | progesterone receptor signaling pathway | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 2 | 6 |
GO:0001055 | RNA polymerase II activity | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 3 | 6 |
GO:0042754 | negative regulation of circadian rhythm | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 2 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 2 | 6 |
GO:0046826 | negative regulation of protein export from nucleus | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 1 | 6 |
GO:0010467 | gene expression | 1.20e-02 | 1.00e+00 | 2.103 | 4 | 49 | 535 |
GO:0032000 | positive regulation of fatty acid beta-oxidation | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 1 | 7 |
GO:2000147 | positive regulation of cell motility | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 2 | 7 |
GO:0007617 | mating behavior | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 1 | 7 |
GO:0010907 | positive regulation of glucose metabolic process | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 1 | 7 |
GO:0000380 | alternative mRNA splicing, via spliceosome | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 2 | 7 |
GO:0006878 | cellular copper ion homeostasis | 1.38e-02 | 1.00e+00 | 6.166 | 1 | 1 | 8 |
GO:0051292 | nuclear pore complex assembly | 1.38e-02 | 1.00e+00 | 6.166 | 1 | 4 | 8 |
GO:0006450 | regulation of translational fidelity | 1.38e-02 | 1.00e+00 | 6.166 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.38e-02 | 1.00e+00 | 6.166 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 1.38e-02 | 1.00e+00 | 6.166 | 1 | 4 | 8 |
GO:0031080 | nuclear pore outer ring | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 2 | 9 |
GO:0090314 | positive regulation of protein targeting to membrane | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 1 | 9 |
GO:0060644 | mammary gland epithelial cell differentiation | 1.56e-02 | 1.00e+00 | 5.996 | 1 | 1 | 9 |
GO:0007049 | cell cycle | 1.67e-02 | 1.00e+00 | 3.320 | 2 | 8 | 115 |
GO:0001967 | suckling behavior | 1.73e-02 | 1.00e+00 | 5.844 | 1 | 4 | 10 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.73e-02 | 1.00e+00 | 5.844 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 1.73e-02 | 1.00e+00 | 5.844 | 1 | 1 | 10 |
GO:0010507 | negative regulation of autophagy | 1.73e-02 | 1.00e+00 | 5.844 | 1 | 1 | 10 |
GO:0001054 | RNA polymerase I activity | 1.73e-02 | 1.00e+00 | 5.844 | 1 | 4 | 10 |
GO:0008643 | carbohydrate transport | 1.73e-02 | 1.00e+00 | 5.844 | 1 | 1 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 1.90e-02 | 1.00e+00 | 5.707 | 1 | 4 | 11 |
GO:0045725 | positive regulation of glycogen biosynthetic process | 1.90e-02 | 1.00e+00 | 5.707 | 1 | 1 | 11 |
GO:0016409 | palmitoyltransferase activity | 2.07e-02 | 1.00e+00 | 5.581 | 1 | 1 | 12 |
GO:0004527 | exonuclease activity | 2.07e-02 | 1.00e+00 | 5.581 | 1 | 4 | 12 |
GO:0031965 | nuclear membrane | 2.10e-02 | 1.00e+00 | 3.144 | 2 | 8 | 130 |
GO:0005666 | DNA-directed RNA polymerase III complex | 2.24e-02 | 1.00e+00 | 5.466 | 1 | 3 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 2.24e-02 | 1.00e+00 | 5.466 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 2.24e-02 | 1.00e+00 | 5.466 | 1 | 3 | 13 |
GO:0006386 | termination of RNA polymerase III transcription | 2.41e-02 | 1.00e+00 | 5.359 | 1 | 3 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 2.41e-02 | 1.00e+00 | 5.359 | 1 | 3 | 14 |
GO:0016746 | transferase activity, transferring acyl groups | 2.41e-02 | 1.00e+00 | 5.359 | 1 | 2 | 14 |
GO:0043393 | regulation of protein binding | 2.41e-02 | 1.00e+00 | 5.359 | 1 | 2 | 14 |
GO:0016575 | histone deacetylation | 2.41e-02 | 1.00e+00 | 5.359 | 1 | 2 | 14 |
GO:0044212 | transcription regulatory region DNA binding | 2.51e-02 | 1.00e+00 | 3.006 | 2 | 13 | 143 |
GO:0005978 | glycogen biosynthetic process | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 2 | 15 |
GO:0018345 | protein palmitoylation | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 1 | 15 |
GO:0000188 | inactivation of MAPK activity | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 1 | 15 |
GO:0070932 | histone H3 deacetylation | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 2 | 15 |
GO:0019706 | protein-cysteine S-palmitoyltransferase activity | 2.92e-02 | 1.00e+00 | 5.078 | 1 | 1 | 17 |
GO:0003899 | DNA-directed RNA polymerase activity | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 3 | 18 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 1 | 19 |
GO:0071897 | DNA biosynthetic process | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 2 | 20 |
GO:0000166 | nucleotide binding | 3.68e-02 | 1.00e+00 | 2.707 | 2 | 13 | 176 |
GO:0006606 | protein import into nucleus | 3.76e-02 | 1.00e+00 | 4.707 | 1 | 3 | 22 |
GO:0046326 | positive regulation of glucose import | 3.76e-02 | 1.00e+00 | 4.707 | 1 | 1 | 22 |
GO:0002376 | immune system process | 3.93e-02 | 1.00e+00 | 4.642 | 1 | 2 | 23 |
GO:0006370 | 7-methylguanosine mRNA capping | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 5 | 24 |
GO:0072659 | protein localization to plasma membrane | 4.10e-02 | 1.00e+00 | 4.581 | 1 | 1 | 24 |
GO:0030901 | midbrain development | 4.27e-02 | 1.00e+00 | 4.522 | 1 | 1 | 25 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 4.27e-02 | 1.00e+00 | 4.522 | 1 | 3 | 25 |
GO:0006360 | transcription from RNA polymerase I promoter | 4.60e-02 | 1.00e+00 | 4.411 | 1 | 4 | 27 |
GO:0050885 | neuromuscular process controlling balance | 4.77e-02 | 1.00e+00 | 4.359 | 1 | 1 | 28 |
GO:0006281 | DNA repair | 4.77e-02 | 1.00e+00 | 2.501 | 2 | 24 | 203 |
GO:0006418 | tRNA aminoacylation for protein translation | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 4 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 6 | 29 |
GO:0042752 | regulation of circadian rhythm | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 5 | 29 |
GO:0016301 | kinase activity | 5.10e-02 | 1.00e+00 | 4.259 | 1 | 2 | 30 |
GO:0005515 | protein binding | 5.22e-02 | 1.00e+00 | 0.616 | 11 | 198 | 4124 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5.27e-02 | 1.00e+00 | 4.212 | 1 | 6 | 31 |
GO:0015030 | Cajal body | 5.43e-02 | 1.00e+00 | 4.166 | 1 | 3 | 32 |
GO:0000910 | cytokinesis | 5.60e-02 | 1.00e+00 | 4.122 | 1 | 2 | 33 |
GO:0007254 | JNK cascade | 5.76e-02 | 1.00e+00 | 4.078 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 5.93e-02 | 1.00e+00 | 4.037 | 1 | 5 | 35 |
GO:0030900 | forebrain development | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 2 | 36 |
GO:0030334 | regulation of cell migration | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 2 | 36 |
GO:0045444 | fat cell differentiation | 6.09e-02 | 1.00e+00 | 3.996 | 1 | 1 | 36 |
GO:0005524 | ATP binding | 6.30e-02 | 1.00e+00 | 1.365 | 4 | 37 | 892 |
GO:0048511 | rhythmic process | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 5 | 38 |
GO:0006417 | regulation of translation | 6.58e-02 | 1.00e+00 | 3.881 | 1 | 2 | 39 |
GO:0006396 | RNA processing | 6.75e-02 | 1.00e+00 | 3.844 | 1 | 4 | 40 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 6.75e-02 | 1.00e+00 | 3.844 | 1 | 6 | 40 |
GO:0003723 | RNA binding | 6.75e-02 | 1.00e+00 | 2.218 | 2 | 22 | 247 |
GO:0004867 | serine-type endopeptidase inhibitor activity | 7.07e-02 | 1.00e+00 | 3.774 | 1 | 1 | 42 |
GO:0001047 | core promoter binding | 7.07e-02 | 1.00e+00 | 3.774 | 1 | 4 | 42 |
GO:0005829 | cytosol | 7.42e-02 | 1.00e+00 | 0.948 | 6 | 88 | 1787 |
GO:0032869 | cellular response to insulin stimulus | 7.88e-02 | 1.00e+00 | 3.611 | 1 | 2 | 47 |
GO:0008203 | cholesterol metabolic process | 7.88e-02 | 1.00e+00 | 3.611 | 1 | 2 | 47 |
GO:0007626 | locomotory behavior | 7.88e-02 | 1.00e+00 | 3.611 | 1 | 1 | 47 |
GO:0032481 | positive regulation of type I interferon production | 8.04e-02 | 1.00e+00 | 3.581 | 1 | 3 | 48 |
GO:0008285 | negative regulation of cell proliferation | 8.25e-02 | 1.00e+00 | 2.052 | 2 | 11 | 277 |
GO:0032587 | ruffle membrane | 8.36e-02 | 1.00e+00 | 3.522 | 1 | 3 | 50 |
GO:0006310 | DNA recombination | 8.36e-02 | 1.00e+00 | 3.522 | 1 | 8 | 50 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 8.68e-02 | 1.00e+00 | 3.466 | 1 | 8 | 52 |
GO:0006289 | nucleotide-excision repair | 8.84e-02 | 1.00e+00 | 3.438 | 1 | 6 | 53 |
GO:0007165 | signal transduction | 8.85e-02 | 1.00e+00 | 1.479 | 3 | 24 | 618 |
GO:0000776 | kinetochore | 9.16e-02 | 1.00e+00 | 3.385 | 1 | 8 | 55 |
GO:0071013 | catalytic step 2 spliceosome | 1.01e-01 | 1.00e+00 | 3.235 | 1 | 5 | 61 |
GO:0006464 | cellular protein modification process | 1.01e-01 | 1.00e+00 | 3.235 | 1 | 4 | 61 |
GO:0000278 | mitotic cell cycle | 1.02e-01 | 1.00e+00 | 1.871 | 2 | 28 | 314 |
GO:0045892 | negative regulation of transcription, DNA-templated | 1.04e-01 | 1.00e+00 | 1.858 | 2 | 17 | 317 |
GO:0003676 | nucleic acid binding | 1.09e-01 | 1.00e+00 | 3.122 | 1 | 4 | 66 |
GO:0006364 | rRNA processing | 1.11e-01 | 1.00e+00 | 3.100 | 1 | 2 | 67 |
GO:0000922 | spindle pole | 1.12e-01 | 1.00e+00 | 3.078 | 1 | 4 | 68 |
GO:0030308 | negative regulation of cell growth | 1.15e-01 | 1.00e+00 | 3.037 | 1 | 3 | 70 |
GO:0010951 | negative regulation of endopeptidase activity | 1.17e-01 | 1.00e+00 | 3.016 | 1 | 2 | 71 |
GO:0006355 | regulation of transcription, DNA-templated | 1.24e-01 | 1.00e+00 | 1.269 | 3 | 31 | 715 |
GO:0042802 | identical protein binding | 1.25e-01 | 1.00e+00 | 1.698 | 2 | 15 | 354 |
GO:0005938 | cell cortex | 1.26e-01 | 1.00e+00 | 2.899 | 1 | 6 | 77 |
GO:0006006 | glucose metabolic process | 1.31e-01 | 1.00e+00 | 2.844 | 1 | 3 | 80 |
GO:0030529 | ribonucleoprotein complex | 1.34e-01 | 1.00e+00 | 2.808 | 1 | 5 | 82 |
GO:0001934 | positive regulation of protein phosphorylation | 1.35e-01 | 1.00e+00 | 2.791 | 1 | 1 | 83 |
GO:0061024 | membrane organization | 1.44e-01 | 1.00e+00 | 2.690 | 1 | 2 | 89 |
GO:0005737 | cytoplasm | 1.47e-01 | 1.00e+00 | 0.611 | 7 | 127 | 2633 |
GO:0008201 | heparin binding | 1.47e-01 | 1.00e+00 | 2.658 | 1 | 4 | 91 |
GO:0007050 | cell cycle arrest | 1.49e-01 | 1.00e+00 | 2.642 | 1 | 4 | 92 |
GO:0016020 | membrane | 1.50e-01 | 1.00e+00 | 0.929 | 4 | 56 | 1207 |
GO:0006260 | DNA replication | 1.52e-01 | 1.00e+00 | 2.611 | 1 | 9 | 94 |
GO:0008286 | insulin receptor signaling pathway | 1.56e-01 | 1.00e+00 | 2.566 | 1 | 2 | 97 |
GO:0006397 | mRNA processing | 1.75e-01 | 1.00e+00 | 2.385 | 1 | 12 | 110 |
GO:0042981 | regulation of apoptotic process | 1.78e-01 | 1.00e+00 | 2.359 | 1 | 4 | 112 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 1.87e-01 | 1.00e+00 | 1.333 | 2 | 29 | 456 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.46e-01 | 1.00e+00 | 1.835 | 1 | 18 | 161 |
GO:0007067 | mitotic nuclear division | 2.52e-01 | 1.00e+00 | 1.800 | 1 | 9 | 165 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 2.69e-01 | 1.00e+00 | 0.981 | 2 | 22 | 582 |
GO:0005743 | mitochondrial inner membrane | 2.93e-01 | 1.00e+00 | 1.544 | 1 | 9 | 197 |
GO:0004674 | protein serine/threonine kinase activity | 2.93e-01 | 1.00e+00 | 1.544 | 1 | 8 | 197 |
GO:0005525 | GTP binding | 2.93e-01 | 1.00e+00 | 1.544 | 1 | 12 | 197 |
GO:0015031 | protein transport | 3.01e-01 | 1.00e+00 | 1.501 | 1 | 10 | 203 |
GO:0019899 | enzyme binding | 3.09e-01 | 1.00e+00 | 1.452 | 1 | 7 | 210 |
GO:0005739 | mitochondrion | 3.20e-01 | 1.00e+00 | 0.802 | 2 | 32 | 659 |
GO:0030198 | extracellular matrix organization | 3.23e-01 | 1.00e+00 | 1.378 | 1 | 7 | 221 |
GO:0007186 | G-protein coupled receptor signaling pathway | 3.32e-01 | 1.00e+00 | 1.327 | 1 | 4 | 229 |
GO:0005730 | nucleolus | 3.57e-01 | 1.00e+00 | 0.502 | 3 | 74 | 1217 |
GO:0008270 | zinc ion binding | 3.65e-01 | 1.00e+00 | 0.660 | 2 | 39 | 727 |
GO:0005886 | plasma membrane | 3.78e-01 | 1.00e+00 | 0.365 | 4 | 46 | 1784 |
GO:0043565 | sequence-specific DNA binding | 3.85e-01 | 1.00e+00 | 1.063 | 1 | 8 | 275 |
GO:0009986 | cell surface | 4.02e-01 | 1.00e+00 | 0.981 | 1 | 5 | 291 |
GO:0006468 | protein phosphorylation | 4.13e-01 | 1.00e+00 | 0.932 | 1 | 6 | 301 |
GO:0006366 | transcription from RNA polymerase II promoter | 4.54e-01 | 1.00e+00 | 0.752 | 1 | 23 | 341 |
GO:0048471 | perinuclear region of cytoplasm | 4.57e-01 | 1.00e+00 | 0.740 | 1 | 11 | 344 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.88e-01 | 1.00e+00 | 0.608 | 1 | 21 | 377 |
GO:0006915 | apoptotic process | 5.19e-01 | 1.00e+00 | 0.483 | 1 | 15 | 411 |
GO:0016032 | viral process | 5.34e-01 | 1.00e+00 | 0.424 | 1 | 30 | 428 |
GO:0045087 | innate immune response | 5.54e-01 | 1.00e+00 | 0.346 | 1 | 12 | 452 |
GO:0070062 | extracellular vesicular exosome | 5.63e-01 | 1.00e+00 | 0.071 | 3 | 51 | 1641 |
GO:0006351 | transcription, DNA-templated | 5.73e-01 | 1.00e+00 | 0.094 | 2 | 47 | 1076 |
GO:0005887 | integral component of plasma membrane | 6.44e-01 | 1.00e+00 | -0.001 | 1 | 8 | 575 |
GO:0016021 | integral component of membrane | 7.69e-01 | 1.00e+00 | -0.410 | 2 | 19 | 1526 |